-
HUVEC – Human Umbilical Vein Endothelial Cells, Single Donor, in EGM™-2Catalog #: C2517A
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from a single donor, in EGMTM-2 containing ≥ 500,000 cells
Sales unit: each -
Pyrotec Pro Lonza IOPQ ServiceCatalog #: 25-338S
PyroTecTM PRO Automated Endotoxin Testing solution Lonza IOPQ service for installation
Sales unit: each -
MEGMTM Mammary Epithelial Cell Growth Medium SingleQuotsTM KitCatalog #: CC-4136Supplements and growth factors required for the culture of Mammary Epithelial Cells (basal media not included)Sales unit: each
-
RtEGM™ Retinal Epithelial Cell Growth Medium SingleQuots™ Supplements and Growth FactorsCatalog #: 00195407
Retinal Epithelial Growth Medium (RtEGM) SingleQuotsTM Supplements and Growth Factors
Sales unit: kit -
ProCHO® 4 Protein-free CHO Medium, 1LCatalog #: BEBP12-029Q
ProCHO® 4 Protein-free CHO Medium with 0.1% Pluronic® F-68 and phenol red, without L-Glutamin, hypoxanthine or thymidine, 1 L
Sales unit: each -
ProCHO® 5 Protein-free CHO Medium Powder kit, 500 LCatalog #: BE15-766L
ProCHO® 5 Protein-free CHO Medium Powder kit with HEPES and 0.1% Pluronic® F-68, without L-Glutamine, phenol red, hypoxanthine or thymidine, 500 L (NAO)
Sales unit: kit -
FBM™ Fibroblast Growth Basal Medium, 500 mLCatalog #: CC-3131
Basal media required for growth of Fibroblasts, 500 mL (supplements and growth factors sold separately).
Need a different format or volume for this media product? Contact Lonza CellBio Services to discuss custom format and formulation options.
Sales unit: each -
TheraPEAKTM ACK Lysing Buffer (1x)Catalog #: BP10-548ETheraPEAK™ ACK Lysing Buffer (1x), 100mLSales unit: Bottle
-
SG Cell Line 96-well Nucleofector® Kit (960 RCT)Catalog #: V4SC-3960
For medium-throughput transfection of cell lines, e.g. Ba/F3, Raji or THP-1, when working with the 4D-Nucleofector® 96-well Unit
Sales unit: kit -
SF Cell Line 96-well Nucleofector® Kit (960 RCT)Catalog #: V4SC-2960
For medium-throughput transfection of cell lines, e.g. K-562, Neuro-2A or RAW246.7, when working with the 4D-Nucleofector® 96-well Unit
Sales unit: kit
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.